» Articles » PMID: 11902671

PPAR Expression and Function During Vertebrate Development

Overview
Journal Int J Dev Biol
Date 2002 Mar 21
PMID 11902671
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

The peroxisome proliferator activated receptors (PPARs) are ligand activated receptors which belong to the nuclear hormone receptor family. As with other members of this superfamily, it is thought that the ability of PPAR to bind to a ligand was acquired during metazoan evolution. Three different PPAR isotypes (PPARalpha, PPARbeta, also called 6, and PPARgamma) have been identified in various species. Upon binding to an activator, these receptors stimulate the expression of target genes implicated in important metabolic pathways. The present article is a review of PPAR expression and involvement in some aspects of Xenopus laevis and rodent embryonic development. PPARalpha and beta are ubiquitously expressed in Xenopus early embryos but become more tissue restricted later in development. In rodents, PPARalpha, PPARbeta and PPARgamma show specific time- and tissue-dependent patterns of expression during fetal development and in the adult animals. PPARs are implicated in several aspects of tissue differentiation and rodent development, such as differentiation of the adipose tissue, brain, placenta and skin. Particular attention is given to studies undertaken by us and others on the implication of PPARalpha and beta in rodent epidermal differentiation.

Citing Articles

PPARs (Peroxisome Proliferator-activated Receptors) and Their Agonists in Alzheimer's Disease.

Kumar M, Sharma A, Datusalia A, Khatik G Med Chem. 2024; 20(8):781-798.

PMID: 38726789 DOI: 10.2174/0115734064295063240422100615.


Molecular pathways in placental-fetal development and disruption.

Adibi J, Zhao Y, Koistinen H, Mitchell R, Barrett E, Miller R Mol Cell Endocrinol. 2023; 581:112075.

PMID: 37852527 PMC: 10958409. DOI: 10.1016/j.mce.2023.112075.


Mechanistic Studies and a Retrospective Cohort Study: The Interaction between PPAR Agonists and Immunomodulatory Agents in Multiple Myeloma.

Wu J, Chu E, Paul B, Kang Y Cancers (Basel). 2022; 14(21).

PMID: 36358696 PMC: 9657746. DOI: 10.3390/cancers14215272.


Modulation of PPAR signaling disrupts pancreas development in the zebrafish, Danio rerio.

Venezia O, Islam S, Cho C, Timme-Laragy A, Sant K Toxicol Appl Pharmacol. 2021; 426:115653.

PMID: 34302850 PMC: 8588802. DOI: 10.1016/j.taap.2021.115653.


Cardiometabolism as an Interlocking Puzzle between the Healthy and Diseased Heart: New Frontiers in Therapeutic Applications.

Pasqua T, Rocca C, Giglio A, Angelone T J Clin Med. 2021; 10(4).

PMID: 33673114 PMC: 7918460. DOI: 10.3390/jcm10040721.